Compreendendo os efeitos farmacológicos dos benzodiazepínicos e o impacto negativo na memória
Main Article Content
Abstract
Benzodiazepines (BZDs) are a class of medications widely effective in the treatment of conditions such as anxiety and insomnia. They work by binding to BZD receptors in the gamma-aminobutyric acid (GABA) receptor complex in the central nervous system. GABA is an inhibitory neurotransmitter that reduces neuronal activity, and BZDs affect GABA-A receptors, making them targets for hypnotic, sedative, and anticonvulsant medications. There are different subtypes of GABA-A receptors with varied functions, and BZDs have affinity for some of these subtypes. These medications play a significant role in modulating neuronal excitability and neural cell communication. Due to their potency, BZDs come with significant adverse effects. Therefore, it is crucial that patients are properly informed about the risks and benefits associated with BZD use. Additionally, supervision by healthcare professionals, including pharmacists, is essential to ensure appropriate use of these medications. To minimize dependence on BZDs, it is important to consider non-pharmacological alternatives, such as cognitive-behavioral therapy and lifestyle adjustments, especially in the treatment of anxiety and insomnia. In summary, a thorough evaluation of BZD use, considering potential effects on memory and cognition, and precise patient guidance are fundamental steps to ensure the rational and safe use of these medications.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in The Brazilian journal of Biomedical Sciences (RBCBM) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work.
This is an open access article under the CC-BY license